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Effects of DOCA-salt treatment on the urinary prostaglandins in Sabra
rats. To determine whether the increased renal synthesis of thrombox-
ane (Tx)A2 found in genetically hypertensive rats also occurred in rats
with a sodium-dependent form of hypertension, the urinary excretion of
6-keto-prostaglandin Fk. (6KPGF1) and of TxB2 was measured by a
sensitive and specific radioimmunoassay in hypertension-prone (SBH),
-resistant (SBN) and unselected (SB) female rats of the Sabra strains.
Rats of the three strains were studied before (9 weeks of age) and after
five weeks of deoxycorticosterone (DOCA)-salt treatment. Before
treatment, the urinary 6KPGFI, did not differ among the three strains
while a higher TxB2 excretion was seen in the SBN rats. After
treatment, the urinary excretion of TxB2 increased significantly in SBH
and SB but not in SBN rats, while the urinary 6KPGF1, remained
unchanged in SBH, increased moderately in SB and markedly in SBN
controls. Consequently, DOCA-salt-induced changes in blood pressure
and in urinary 6KPGF observed in the three strains of rats were
inversely related (r —0.78; P < 0.001). It is concluded that the high
blood pressure developed after DOCA-salt treatment in SBH rats is
more likely to depend upon a defect in the renal production of
prostacyclin rather than upon an increased synthesis of thromboxane
A2.
Prostacyclin (PGI2) and Thromboxane (Tx) A2 are known to
influence, in an opposite way, vascular smooth muscle func-
tion, urinary excretion of electrolytes and platelet aggregation
[1—3]. Therefore, it was of interest to investigate their possible
role in the pathophysiology of hypertension (HTA).
Since prostaglandins (PGs) act locally or close to the site of
their synthesis, most of the studies used in vitro measurements
of PGs released by tissue samples [4, 5]. However, in order to
use animals maintained in physiological conditions, in vivo
experiments have been developed, based on the measurement
of urinary excretion of unmetabolized PGs since it was demon-
strated that: I.) it is a reliable index of the PGs biosynthesis by
the kidney [6, 7], a key organ in blood pressure (BP) regulation;
and II.) a defect in the renal production of PGs is often
associated with a similar defect in other tissues [5]. Under such
conditions, it has been shown that, in genetically hypertensive
rats of the Japanese (SHR) and of the Lyon (LH) strains, there
is an increase in the renal synthesis of TxA2 [8, 9]. In order to
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determine if such an elevated renal production of TxA2 could be
found in all forms of genetic HTA, we thought it to be of interest
to measure the urinary excretion of PGs in a sodium-dependent
model of genetic hypertension. Therefore, in the present work,
we studied the urinary excretion of 6-keto-prostaglandin F1,
(6KPGF1a) and TxB2, the stable break-down products of PGI2
and TxA2, respectively, in a model of rats genetically sensitive
(Sabra hypertension-prone, SBH) or resistant (Sabra hyperten-
sion-resistant, SBN) to a deoxycorticosterone (DOCA)-salt
treatment [101. In addition, unselected rats of the original stock
(Sabra, SB) were also studied.
Methods
The study was conducted in groups of eight age-matched
SBH, SBN and unselected SB female rats, maintained on a
regular diet (Purina Chow, Amrod 931, Ambar Food Mills,
Hadera, Israel). Nine week-old rats, receiving tap water ad
libitum, were first placed into individual metabolic cages; after
the animals had been submitted to a 48 hour period of habitu-
ation, urines were collected for 24 hours at + 4°C. Then, all the
rats underwent DOCA pellet implantation (25 mg s.c.) and
drinking water was replaced by 0.9% NaCl for the following five
weeks. At the end of this period, urines were collected again for
24 hours in the same conditions.
Systolic blood pressure (SBP), recorded by tail cuff plethys-
mography (USH-l05 automatic BP recorder) and body weights
were measured in 9 and 14 week-old animals. Urinary electro-
lytes were determined by flame photometry and urinary PGs
were measured using our previously described methodology
[11, 12]. Briefly, in this technique, urinary PGs were first
extracted by ethyl acetate and then submitted, prior to radio-
immunoassay, to a reversed phase high performance liquid
chromatographic separation. This step, performed on a column
packed with Nucleosil C18 (particle size, 10 m) and using a
mobile phase made of water, acetonitrile and acetic acid (79:
21:0.1), is of major interest since it permits a separation of
6KPGF1, and TxB2 not only from the other primary PGs, but
also from their respective dinor derivatives. Indeed, the reten-
tion times were 4.30 and 6.50 minutes for 6KPGF1, and TxB2,
respectively, and 17.40 and 3.80 minutes for their respective
dinor derivatives. Therefore, although the anti-6KPGF1, and
anti-TxB2 antibodies used exhibited some degrees of cross-
reactions toward the corresponding dinor derivatives only (10.7
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Fig. 1. Body weight (g), systolic blood pressure
(SBP, ,n,n Hg), urinary excretion of 6KPGF,,
and TxB2 (ng124 hr/100 g) observed in SBH(A- -
-A), SB (•—•) and SBN (0- --0)
rats before (9 week-oId and after (/4 week-old)
After DOCA -salt treatment. • P < 0.05; •• P < 0.01;
••• P < 0.001 vs. SB Rats. 0 P < 0.05; COP <OCA-saIt 0.01; 000 P <0.00! vs. SBN Rats.
N ml/24 hr//OO g Ixmol/24 hrIlOO g
SBH
Control
DOCA-salt
6
7
5.0 0.8
P < 0.0!
21.8
528 61
P < 0.01
3111 l84'
666 81
P < 0.01
1159 39
0.80 0.0lc
P < 0.01
2.69 0. 16.d
SB
Control
DOCA-salt
8
6
7.0 0.5
P<O.0l
32.3 1.7
682 38
P<0.0l
4547 204
882 47
P<0.05
1276 116
0.77 0.02
P<0.0l
3.68 0.29
SBN
Control
DOCA-salt
8
6
6.3 0.5
P<0.0l
26.7 2.4
505 31
P<0.01
3710 394
772 48
NS
1090 139
0.66 003b
P<0.01
3.54 0.26
and 26.7%, respectively), 6KPGF1 or TxB2 are not collected
together with their respective dinor metabolites which permits
an avoidance of any interference during the radioimmunoassay.
Finally, sensitivities of the assays were 1.4 pg for 6KPGF1. and
0,7 pg for TxB2.
In order to take into account the large body weight differ-
ences exhibited by the three strains, the urinary data were
corrected for body weight according to Ben-Ishay [13, 141. The
results are expressed as mean SEM. Further statistical anal-
ysis used Wilcoxon's test for paired and unpaired data.
Results
Before DOCA-salt treatment (Fig. 1), 9 week-old SBH rats
exhibited a larger body weight than SBN but not than SB rats,
while their SBP was already significantly higher than that of
both SB and SBN controls. The urinary excretion of 6KPGF1,
corrected for body weight, did not differ among the three
strains, while excretion of TxB2 exhibited a significant increase
in SBN rats. As indicated in Table 1, diuresis as well as sodium
and potassium excretion showed no obvious interstrain differ-
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Table 1. Effects of a 5 week 1)OCA-salt treatment on the twenty-tour hour urine volume, urinary excretion of sodium and potassium and on
the sodium/potassium ratio in SBH, SB and SBN rats
V
UN,V UKV
Na/K
ratio
Abbreviations are: V, urine volume; UNaV, sodium excretion; UKV, potassium excretion.Values are mean sEM; N denotes the number of
animals in each group.a P < 0.05; b P < 0.01; C P < 0.01)1 compared to SB rats; d P < 0.05; P <0.01 compared to SBN rats
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ences with the exception of a significantly reduced Na/K ratio in
SBN rats.
After five weeks of DOCA-salt treatment (Table I, Fig. 1),
the SBP of SBFI rats increased markedly, while that of SB was
slightly elevated and that of SBN remained unchanged. The
urinary excretion of TxB2 increased slightly in the three strains
but more markedly so in SB than in SBH and SBN rats. On the
contrary, the urinary excretion of 6KPGF1 remained stable in
SBH but increased in SB and even more so in SBN rats.
Consequently, when considering the three strains of rats, a
significant inverse relationship (r = —0.78; N = 17; P < 0.001)
was observed between the DOCA-salt-induced changes in SBP
and in the excretion of urinary 6KPGF1 (Fig. 2). The diuresis
and the urinary output of sodium and potassium increased in the
three groups; although not significantly, the increase in the
urinary elimination of sodium was lower in SBH (674 93%)
than in SB (694 70%) and SBN (766 110%) rats.
Discussion
The present study was designed to determine whether the
increased TxA2 biosynthesis, which has been demonstrated to
occur in young genetically hypertensive rats of the Japanese [8]
and of the Lyon [91 strains, also occurs in other forms of genetic
HTA.
For that purpose, we studied rats of the Sabra strains which
are genetically sensitive (SBH) or resistant (SBN) to a DOCA-
salt treatment [10]. This model was developed according to the
same principle that the DahI's strains, but the animals were
subsequently selected on the basis of their SBP response to salt
plus DOCA administration. In addition, unselected rats of the
original stock (SB) were also used as controls. Such a model is
of high interest since, as previously shown using the Lyon
model of genetically hypertensive rats [15], it enables the
researcher to discriminate, between strain differences, those
which can be related to HTA (SBH differ from both SBN and
SB rats) and other genetic differences which are unlikely determi-
nants of HTA (SBH differ from either SBN or SB rats only).
The renal synthesis of PGs was assessed by their urinary
excretion which is usually considered as a valid index of their
renal biosynthesis [6, 7]. In opposition to the in vitro tech-
niques, such an approach allows the same animal at different
ages and in strictly physiological conditions to be followed.
Furthermore, the use of female, instead of male rats, which
excludes any possibility of seminal fluid contamination of
urines, and the use of specific techniques of measurements [Ii,
121 which discriminate between unmetabolized PGs and meta-
bolic products, allow accurate data to be obtained.
As previously reported by Ben-Ishay [16], SBH rats exhibit-
ed, before the administration of DOCA-salt, a slightly but
significantly increase in SBP compared to SBN or SB rats,
associated with a slight decrease in their diuresis. The urinary
excretion of 6KPGF1,. did not differ among the three groups of
rats while the urinary excretion of TxB2 was found to be
decreased in SBH rats compared to SBN but not to SB animals.
A 5 week-DOCA-salt treatment strikingly enhanced the SBP
of SBH but not of SBN and SB animals. Diuresis, natriuresis
and kaliuresis were markedly higher than before DOCA-salt
treatment in the three groups of rats, and the excretion of
sodium was slightly less affected in SBH rats than in the two
other strains. Although not significant, this finding is in keeping
with the data reported by Mekler, Yagil and Ben-Ishay [131 and
permits a suggestion that a mild sodium retention could occur in
SBH rats since salt consumption [171 and intestinal sodium
absorption [14] did not differ between the three strains. After
DOCA-salt, an overall increase in the excretion of both PGs
was observed. This increase is unlikely to be the consequence
of aging since the urinary PGs, corrected for body weight, have
been shown to decrease with age in the DahI [181, Japanese [19]
and Lyon [9] strains of rats. Since high sodium diet was found
to result in an overall stimulation of renal PGE2 [18, 20] and '2
[21] biosynthesis in both Dahl's sensitive and resistant rats, the
above described elevation in the urinary excretion of PGs
appears more likely to be the consequence of salt-loading. In
that respect, it is interesting to observe that, after DOCA-salt,
the urinary excretion of TxB2 is lower in SBFI than in SB and,
even more so, than in SBN rats. Taken together with the low
urinary TxB2 levels observed in SBH before the administration
of DOCA, these results demonstrate that the high SBP exhib-
ited by SBH rats is not associated with an enhanced renal
synthesis of the vasoconstrictor TxA2, a finding which differs
from that reported in both SHR 18] and LH [91 strains.
On the contrary, the major defect in the PGs biosynthesis
exhibited by SBH appears to be an impaired ability to increase
their production of the vasodilator and natriuretic PGI2 in
response to DOCA-salt. Furthermore, the close inverse rela-
tionship (r = —0.78; P < 0.001) observed in the three strains
between the changes in SBP and in the urinary excretion of PGs
under DOCA-salt treatment suggests a possible link between
the DOCA-salt sensitivity and the production of prostacyclin. It
is noteworthy that biosynthesis of the vasodilator PGs which is
increased in SHR and LH rats [8, 9] has been reported to be
decreased in Dahi sensitive rats [18, 20, 211 as in the Sabra rats
of the present study, which suggests that this defect could
constitute a common and specific feature of these two sodium-
dependent forms of HTA.
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Fig. 2. Relationship between the DOA -salt induced changes in sys-
tolic blood pressure (SBP; % of pre-DOCA-salt values) and urinary
6-keto-prostaglandin F1 (6KPGF,,; % of pre-DOCA-salt valuer) in
SBH (A), SB (•) and SBN (0) rats.
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In conclusion, SBH rats differ from genetic hypertensive rats
by the absence of an increased TxB2 production. On the other
hand, the major defect exhibited by SBH rats is an impaired
ability to enhance their renal production of PG!2 during a
DOCA-salt treatment. Since the kidney plays an important role
in BP regulation and since PG!2 exhibits marked vasodilator
and natriuretic properties, such a decreased PG!2 renal produc-
tion could be of importance in the hypertension developed in
SBH rats. Such an hypothesis is strengthened by the inverse
relationship found between SBP levels and urinary 6KPGF,,.
DOCA-salt-induced changes in the three strains of rats studied.
The origin of such a defect requires further investigations.
However, this study establishes that genetically hypertensive
rats and rats genetically prone to develop a sodium-dependent
form of HTA could exhibit different patterns in their PGs
biosynthesis.
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